Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US00287Y1091
Ticker ABBV
Company ABBVIE
Currency $
Price
Aware Investor Index (AII) 599.7225
Recommendation STRONG BUY
P/E 26.57
ROE 100.00 %
Capitalization 120,959,040,000 $
Dividend Yield 5.05 %
P/S 3.69
AII Position 11
P/E Position 400
ROE Position 21
Capitalization Position 64
Dividend Yield Position 86
Sales 32,753,000,000 $
10-Year Average Earnings 4,551,700,000 $
Shares Outstanding 1,546,000,000
Equity -8,446,000,000 $
Dividend per Share 3.95 $
Industry Pharmaceutical
Country United States
ABBVIE Investor Relations Web Site http://www.abbvieinvestor.com







Sales:

YEAR MONTH AMOUNT
2018 12 32,753,000,000.00 $
2017 12 28,216,000,000.00 $
2016 12 25,638,000,000.00 $
2015 12 22,859,000,000.00 $
2014 12 19,960,000,000.00 $
2013 12 18,790,000,000.00 $
2012 12 18,380,000,000.00 $
2011 12 17,444,000,000.00 $
2010 12 15,638,000,000.00 $
2009 12 14,214,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 5,687,000,000.00 $
2017 12 5,309,000,000.00 $
2016 12 5,953,000,000.00 $
2015 12 5,144,000,000.00 $
2014 12 1,774,000,000.00 $
2013 12 4,128,000,000.00 $
2012 12 5,275,000,000.00 $
2011 12 3,433,000,000.00 $
2010 12 4,178,000,000.00 $
2009 12 4,636,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 -8,446,000,000.00 $
2017 12 5,097,000,000.00 $
2016 12 4,636,000,000.00 $
2015 12 3,945,000,000.00 $
2014 12 1,742,000,000.00 $
2013 12 4,492,000,000.00 $
2012 12 3,363,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 1,546,000,000
2017 12 1,603,000,000
2016 12 1,631,000,000
2015 12 1,637,000,000
2014 12 1,610,000,000
2013 12 1,604,000,000
2012 12 1,577,000,000

 












Bloomberg News for ABBVIE:



Google News for ABBVIE:

Seeking Alpha - 2 hours ago
5 Reasons AbbVie Is My Biggest Holding
... 52-week lows, WBA and ABBV. There are five reasons why I boosted my position in AbbVie by $8K, making it my biggest holding and 15% of ...
Zacks.com - 42 minutes ago
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
ABBV will be looking to display strength as it nears its next earnings release. In that report, analysts expect ABBV to post earnings of $2.05 per ...
Motley Fool - 1 day ago
2 Things Investors Are Missing About AbbVie
AbbVie (NYSE:ABBV) has seen better days. After a 54% gain in 2017, the big-pharma stock lost ground last year. So far in 2019, AbbVie's ...
Fairfield Current
AbbVie Inc. (ABBV): The Stock You Should Be Taking Seriously
ABBV shares have a strong debt-to-equity ratio but their quick ratio which reads 0.90 is strong and might cause problems for them later in the ...
FinBulletin
Why Analyst's Bullish on these two stock: AbbVie Inc. (ABBV), Dell ...
AbbVie Inc. (NYSE: ABBV) experienced a high price of $81.46 with a low value of $79.11 at the end of the last trading session, which followed ...
The Hi New Ulm
As Abbvie (ABBV) Stock Value Declined, Tctc Holdings Increased Its ...
Tctc Holdings Llc increased its stake in Abbvie Inc (ABBV) by 5.19% based on its latest 2018Q4 regulatory filing with the SEC. Tctc Holdings Llc ...
CryptoAmber - 7 hours ago
As Abbvie (ABBV) Share Price Declined, Menlo Advisors Cut Its ...
As Abbvie (ABBV) Share Price Declined, Menlo Advisors Cut Its Stake; Garrison Financial Stake In Jb Hunt Transportation Service (JBHT) Was ...
The FinHeadLines
Should Value Investors Consider Abbvie (ABBV) Stock Now?
Let's put Abbvie Inc. ABBV stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors ...
Financial Mercury
Trading Monitor on This Stock: AbbVie Inc. (NYSE:ABBV)
The HMA or Hull Moving Average for AbbVie Inc. (NYSE:ABBV) is presently 80.92259. The HMA may help with technical analysis by reducing ...
The Moveefy
AbbVie (ABBV) Gains But Lags Market: What You Should Know
AbbVie (ABBV) closed the most recent trading day at $78.08, moving +0.64% from the previous trading session. This change lagged the S&P ...


Back